Cerebral venous thrombosis
Cerebral Venous Thrombosis Cerebral venous thrombosis is characterized by infarction with
focal neurologic deficits and increased intracranial pressure. As a very rare complication of …
focal neurologic deficits and increased intracranial pressure. As a very rare complication of …
Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta‐analysis
Cerebral venous thrombosis (CVT) is caused by partial or complete occlusion of the major
cerebral venous sinuses or the smaller feeding cortical veins which predispose to the risk of …
cerebral venous sinuses or the smaller feeding cortical veins which predispose to the risk of …
International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants
RC Gosselin, DM Adcock, SM Bates… - Thrombosis and …, 2018 - thieme-connect.com
This guidance document was prepared on behalf of the International Council for
Standardization in Haematology (ICSH) for providing haemostasis-related guidance …
Standardization in Haematology (ICSH) for providing haemostasis-related guidance …
[图书][B] Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19)
World Health Organization - 2023 - apps.who.int
1.1 Background Since March 2021, cases of thromboses associated with thrombocytopenia
have been reported in patients vaccinated with the Oxford-AstraZeneca ChAdOx1-S and …
have been reported in patients vaccinated with the Oxford-AstraZeneca ChAdOx1-S and …
2021 update of the International Council for Standardization in Haematology recommendations for laboratory measurement of direct oral anticoagulants
J Douxfils, DM Adcock, SM Bates… - Thrombosis and …, 2021 - thieme-connect.com
In 2018, the International Council for Standardization in Haematology (ICSH) published a
consensus document providing guidance for laboratories on measuring direct oral …
consensus document providing guidance for laboratories on measuring direct oral …
Study of rivaroxaban for cerebral venous thrombosis: a randomized controlled feasibility trial comparing anticoagulation with rivaroxaban to standard-of-care in …
BACKGROUND: Emerging data suggest that direct oral anticoagulants may be a suitable
choice for anticoagulation for cerebral venous thrombosis (CVT). However, conducting high …
choice for anticoagulation for cerebral venous thrombosis (CVT). However, conducting high …
Updates in cerebral venous thrombosis
A Alimohammadi, DJ Kim, TS Field - Current Cardiology Reports, 2022 - Springer
Abstract Purpose of Review Cerebral venous thrombosis (CVT) is a rare cause of stroke that
most commonly affects younger women. Here, we review new literature relevant to the …
most commonly affects younger women. Here, we review new literature relevant to the …
50 Years of pediatric hemostasis: knowledge, diagnosis, and treatment
S Levy-Mendelovich, O Cohen… - … in Thrombosis and …, 2023 - thieme-connect.com
Studies from the past 50 years have contributed to the expanding knowledge regarding
developmental hemostasis. This is a dynamic process that begins in the fetal phase and is …
developmental hemostasis. This is a dynamic process that begins in the fetal phase and is …
Cerebral venous sinus thrombosis in traumatic brain injury: a systematic review of its complications, effect on mortality, diagnostic and therapeutic management, and …
DF Netteland, EC Sandset… - Frontiers in …, 2023 - frontiersin.org
Objective Cerebral venous sinus thrombosis (CVST) is increasingly being recognized in the
setting of traumatic brain injury (TBI), but its effect on TBI patients and its management …
setting of traumatic brain injury (TBI), but its effect on TBI patients and its management …
Diagnosis and Treatment of Cerebral Venous Thrombosis
AL Liberman - CONTINUUM: Lifelong Learning in Neurology, 2023 - journals.lww.com
OBJECTIVE Cerebral venous thrombosis (CVT), thrombosis of the dural sinus, cerebral
veins, or both, is a rare cerebrovascular disease. Although mortality rates after CVT have …
veins, or both, is a rare cerebrovascular disease. Although mortality rates after CVT have …